Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Silagen is a premier brand of medical-grade silicone scar treatment products, primarily serving the plastic surgery and dermatology markets. The company offers a comprehensive line of physician-exclusive products, including silicone gels, gels with SPF 30, and various shapes of silicone sheeting designed to prevent and treat hypertrophic scars and keloids. Originally a brand under Enterprise Medical, it was acquired by Sientra in 2016 and subsequently became part of Tiger Aesthetics Medical following Sientra's asset sale in 2024. Silagen products are recognized for using high-quality, medical-grade silicone to provide a protective barrier that hydrates scar tissue and normalizes collagen synthesis. The brand is distinguished by its commitment to physician-only distribution, ensuring professional oversight for scar management. Its clinical efficacy makes it a standard recommendation for post-operative care in aesthetic and reconstructive procedures.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Silagen.